Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network

Autor: Al Mansour, Laure, De Mestier, Louis, Haissaguerre, Magalie, Afchain, Pauline, Hadoux, Julien, Lecomte, Thierry, Morland, David, Cottereau, Anne Segolene, De Rycke, Ophelie, Tlili, Ghoufrane, Tordo, Jérémie, Janier, Marc, Deville, Agathe, Walter, Thomas
Zdroj: Journal of Nuclear Medicine; Aug2024, Vol. 65 Issue 8, p1-6, 6p
Databáze: Complementary Index